Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-11 Sale |
2025-02-12 9:23 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER |
11,375 | $24.04 | $273,455 | 419,173 (Direct) |
View |
| 2025-02-03 Sale |
2025-02-04 8:30 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER |
50,691 | $20.21 | $1,024,343 | 690,548 (Direct) |
View |
| 2025-01-22 Sale |
2025-01-23 8:39 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER |
10,736 | $19.46 | $208,923 | 351,239 (Direct) |
View |
| 2024-09-09 Sale |
2024-09-09 9:20 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER |
21,125 | $11.52 | $243,360 | 361,975 (Direct) |
View |
| 2024-02-01 Sale |
2024-02-02 4:06 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER |
19,122 | $8.7039 | $166,435 | 710,600 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-25 4:10 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER |
7,873 | $8.96 | $70,542 | 234,722 (Direct) |
View |
| 2023-09-05 Sale |
2023-09-05 8:10 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
4,455 | $14.71 | $65,533 | 242,595 (Direct) |
View |
| 2023-02-01 Sale |
2023-02-02 6:58 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
8,196 | $22.25 | $182,361 | 529,650 (Direct) |
View |
| 2023-01-24 Sale |
2023-01-26 4:05 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
6,442 | $21.5 | $138,503 | 147,846 (Direct) |
View |
| 2023-01-05 Sale |
2023-01-06 4:05 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
5,625 | $20.75 | $116,719 | 154,288 (Direct) |
View |
| 2022-02-10 Sale |
2022-02-11 4:05 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
4,832 | $27.84 | $134,523 | 159,913 (Direct) |
View |
| 2022-01-31 Sale |
2022-02-02 4:16 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
4,813 | $27.4 | $131,876 | 372,145 (Direct) |
View |
| 2022-01-24 Sale |
2022-01-26 4:33 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
7,873 | $24.98 | $196,668 | 131,710 (Direct) |
View |
| 2022-01-04 Sale |
2022-01-06 4:03 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
17,332 | $30.08 | $521,407 | 139,583 (Direct) |
View |
| 2021-08-17 Sale |
2021-08-17 7:40 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
7,836 | $17.12 | $134,142 | 156,915 (Direct) |
View |
| 2021-06-01 Sale |
2021-06-03 4:07 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
9,562 | $14.62 | $139,797 | 147,251 (Direct) |
View |
| 2021-02-05 Sale |
2021-02-09 4:28 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
9,626 | $31.5 | $303,171 | 156,813 (Direct) |
View |
| 2021-02-03 Sale |
2021-02-03 9:29 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
2,406 | $28.91 | $69,557 | 148,939 (Direct) |
View |
| 2021-02-02 Sale |
2021-02-02 9:20 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
8,734 | $29.91 | $261,267 | 151,345 (Direct) |
View |
| 2021-01-05 Sale |
2021-01-07 6:29 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
6,876 | $26.83 | $184,483 | 87,819 (Direct) |
View |
| 2020-09-21 Sale |
2020-09-22 9:15 pm |
Retrophin Inc. | RTRX | Dube Eric M Chief Executive Officer |
10,805 | $19.28 | $208,319 | 94,695 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-31 Option Award |
2025-02-04 8:30 pm |
N/A 2035-01-31 |
Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER |
390,000 | $0 | 690,548 (Direct) |
View |
| 2024-09-05 Option Award |
2024-09-09 9:20 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER |
32,500 | $0 | 361,975 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 4:06 pm |
N/A 2034-01-30 |
Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER |
495,000 | $0 | 710,600 (Direct) |
View |
| 2023-08-31 Option Award |
2023-09-05 8:10 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
9,900 | $0 | 242,595 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 6:02 pm |
N/A 2033-06-05 |
Reneo Pharmaceuticals Inc. | RPHM | Dube Eric M Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 6:58 pm |
N/A 2033-01-30 |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
390,000 | $0 | 529,650 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 5:00 pm |
N/A 2032-05-31 |
Reneo Pharmaceuticals Inc. | RPHM | Dube Eric M Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 4:16 pm |
N/A 2032-01-30 |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
245,248 | $0 | 372,145 (Direct) |
View |
| 2021-08-13 Option Award |
2021-08-17 7:40 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
17,500 | $0 | 156,915 (Direct) |
View |
Ownership |
2021-04-08 4:57 pm |
2021-03-12 2031-03-11 |
Reneo Pharmaceuticals Inc. | RPHM | Dube Eric M Director |
0 | $0 | 44,694 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 4:46 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
17,500 | $0 | 166,439 (Direct) |
View |
| 2021-01-31 Option Award |
2021-02-02 9:20 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
15,000 | $0 | 151,345 (Direct) |
View |
| 2021-01-21 Option Award(A) |
2021-01-28 8:00 pm |
N/A 2031-01-20 |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
212,660 | $0 | 212,660 (Direct) |
View |
| 2021-01-21 Option Award |
2021-01-25 8:54 pm |
N/A 2031-01-20 |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
269,860 | $0 | 357,679 (Direct) |
View |
| 2020-09-18 Option Award |
2020-09-22 9:15 pm |
N/A N/A |
Retrophin Inc. | RTRX | Dube Eric M Chief Executive Officer |
28,000 | $0 | 94,695 (Direct) |
View |